NEWSROOM

Perspectives on IP strategy, portfolio development, and the factors that shape how patents perform in practice. 

Hylton-Rodic Law, Life Sciences IP, Events & Thought Leadership, European & U.S. Patent Strategy Guest User Hylton-Rodic Law, Life Sciences IP, Events & Thought Leadership, European & U.S. Patent Strategy Guest User

REFLECTIONS FROM MUNICH: A SUMMIT ON LIFE SCIENCES STRATEGY ON IP & EXCLUSIVITY

We’ve just returned from the Life Sciences Strategy Summit in Munich, where Keisha Hylton-Rodic joined global experts to explore divisional patenting and the evolving IP landscape. The conversations were rich, the insights actionable, and the collaboration inspiring.

Read More